Cabot Acquire Technology for Producing Next Generation Tantalum Powders

Cabot Corporation Acquires Assets of AP Materials, Inc., of St. Louis, Missouri Cabot Supermetals to utilize technology platform to create next generation tantalum powders Boston, MA and St. Louis, Missouri -- Cabot Corporation announced today that it has acquired the assets and technology of AP Materials, Inc., of St. Louis, Missouri.

AP Materials is an advanced materials company that produces high-purity powders for industrial applications using a novel flame process to create high surface area powders that are non-reactive and oxide free. AP Materials has used its proprietary manufacturing process to develop next generation tantalum powders. AP Materials licensed its core technology from Washington University in St. Louis, and has assigned its rights to Cabot.

Cabot Supermetals Vice President and General Manager, Eduardo Cordeiro said, “The flame synthesis technology developed by AP Materials provides an exciting new platform for the manufacture of high surface area metal and metal alloy powders. We believe this technology will provide opportunities to bring new products to the marketplace and further enhance Cabot's position as the leading supplier of tantalum powders to the electronics industry.”

AP Materials' Chairman, Richard Axelbaum, Ph.D., Associate Professor, Department of Energy, Environmental and Chemical Engineering at Washington University said, “AP Materials has advanced a fledgling technology using funding from our loyal investors, federal grants and others. The technology is now at a stage where further commercialization can best be achieved through the resources of a major corporation, such as Cabot Corporation. With its core competencies in flame technologies and tantalum processing, Cabot is ideally suited to utilize our flame synthesis process to produce more advanced tantalum and exploit it to the fullest.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.